Comparison of the cytotoxicity of amsacrine and its analogue CI-921 against cultured human and mouse bone marrow tumour cells
- 31 January 1990
- journal article
- research article
- Published by Elsevier BV in European Journal of Cancer and Clinical Oncology
- Vol. 26 (1), 49-54
- https://doi.org/10.1016/0277-5379(90)90256-s
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The clinical pharmacokinetics of N-5-dimethyl-9-[(2-methoxy-4-methyl-sulfonylamino)phenylamino]-4-acridinecarboxamide (CI-921) in a phase 1 trialCancer Chemotherapy and Pharmacology, 1988
- Derivatives of Amsacrine: Determinants Required for High Activity Against Lewis Lung CarcinomaJNCI Journal of the National Cancer Institute, 1988
- Mechanism of resistance of non-cycling mammalian cells to 4′-[9-acridinylamino]methanesulphon-m-anisidide: Role of DNA topoisomerase II in log- and plateau-phase CHO cellsBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1988
- Comparison of in Vitro activity of cytotoxic drugs towards human carcinoma and leukaemia cell linesEuropean Journal of Cancer and Clinical Oncology, 1986
- The use of human cancer cell lines as a primary screening system for antineoplastic compoundsEuropean Journal of Cancer and Clinical Oncology, 1984
- Differential growth inhibition of cultured mammalian cells: Comparison of clinical antitumour agents and amsacrine derivativesEuropean Journal of Cancer and Clinical Oncology, 1984
- Myelo-lymphopoietic stem cells in human bone marrowBlut: Zeitschrift für die Gesamte Blutforschung, 1982
- Treatment of acute myeloid leukaemia with a triple cytotoxic regime: datBritish Journal of Cancer, 1977
- The experimental antitumour properties of three congeners of the acridylmethanesulphonanilide (AMSA) seriesEuropean Journal of Cancer (1965), 1974
- Cytological Identification of Radiation-ChimærasNature, 1956